La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Vaxart a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Vaxart..

Vaxart (NASDAQ:VXRT) Azioni, Catena delle Opzioni

Vaxart

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Vaxart Inc

WIIM

DLTR

OLLI

Shares of discount store stocks are trading higher after Five Below raised its Q1 outlook.

<p>RBC Capital  analyst Luca Issi   maintains Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) with a Sector Perform and lowers the price target from $32 to $28.</p>


News

Price Target

Analyst Ratings

MRNA

RBC Capital Maintains Sector Perform on Moderna, Lowers Price Target to $28

<p><strong>Mueller Water Products</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MWA#NYSE">MWA</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-05. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Mueller Water Products will report an <strong>earnings per share</strong> (EPS) of $0.31. </p>
<p>Anticipation surrounds Mueller Water Products's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.06, leading to a 16.68% increase in the share price on the subsequent day.</p>
<p>Here's a look at Mueller Water Products's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.19</td>
<td>0.21</td>
<td>0.22</td>
<td>0.14</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.25</td>
<td>0.22</td>
<td>0.32</td>
<td>0.30</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>17.0%</td>
<td>0.0%</td>
<td>6.0%</td>
<td>9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746212746_0.png" alt="eps graph" /></p>
<h3>Market Performance of Mueller Water Products's Stock</h3>
<p>Shares of Mueller Water Products were trading at $26.56 as of May 01. Over the last 52-week period, shares are up 64.54%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Insights on Mueller Water Products</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Mueller Water Products.</p>
<p>The consensus rating for Mueller Water Products is Neutral, derived from 2 analyst ratings. An average one-year price target of $29.0 implies a potential 9.19% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of ESCO Technologies, Timken and Franklin Electric, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for ESCO Technologies, with an average 1-year price target of $182.5, suggesting a potential 587.12% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Timken, with an average 1-year price target of $81.5, suggesting a potential 206.85% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Franklin Electric, with an average 1-year price target of $94.0, suggesting a potential 253.92% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary outlines pivotal metrics for ESCO Technologies, Timken and Franklin Electric, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mueller Water Products</td>
<td>Neutral</td>
<td>18.68%</td>
<td>$103M</td>
<td>4.29%</td>
</tr>
<tr>
<td>ESCO Technologies</td>
<td>Buy</td>
<td>13.15%</td>
<td>$98.38M</td>
<td>1.90%</td>
</tr>
<tr>
<td>Timken</td>
<td>Neutral</td>
<td>-4.20%</td>
<td>$358.70M</td>
<td>2.73%</td>
</tr>
<tr>
<td>Franklin Electric</td>
<td>Neutral</td>
<td>-6.28%</td>
<td>$164.24M</td>
<td>2.41%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Mueller Water Products ranks in the middle among peers for Consensus rating. It ranks at the bottom for Revenue Growth. It is at the top for Gross Profit. It is in the middle for Return on Equity.</p>
<h3>Unveiling the Story Behind Mueller Water Products</h3>
<p>Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.</p>
<h3>Financial Milestones: Mueller Water Products's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Mueller Water Products's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>18.68%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Mueller Water Products's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>11.6%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Mueller Water Products's ROE excels beyond industry benchmarks, reaching <strong>4.29%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Mueller Water Products's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.17%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.57</strong>.</p>
<p><a href="https://www.benzinga.com/quote/MWA/earnings"><strong>To track all earnings releases for Mueller Water Products visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

A Preview Of Mueller Water Products's Earnings

<p>Piper Sandler  analyst Arvind Ramnani   downgrades Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) from Overweight to Neutral and lowers the price target from $85 to $51.</p>


Downgrades

Piper Sandler Downgrades Block to Neutral, Lowers Price Target to $51

<p>In this current era of whiplash volatility, investors are forced to engage in a daily tug-of-war between the excitement of the next market rally and the fear of another devastating drawdown. </p>
<p>The <a href="https://www.benzinga.com/etfs">actively managed fund</a>, <strong>TappAlpha SPY Growth &amp; Daily Income ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSPY#NASDAQ">TSPY</a>), is designed to straddle the tightrope between capital protection, income, and growth. </p>
<p>TappAlpha CEO<strong> Si Katara</strong> chatted with Benzinga about having a specific strategy, rather than guessing the stock market.</p>
<p>At its essence, TSPY has dollar-for-dollar exposure to  <strong>SPDR S&amp;P 500 </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), the well-known S&amp;P 500 ETF that&#8217;s frequently a bedrock of long-term portfolios (and even <strong>Warren Buffett</strong>&#8216;s go-to passive play). But TSPY incorporates a next-gen spin: a daily options overlay designed to create reliable, tax-effective income — even in volatile markets.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/05/45153699/new-etf-bets-on-small-companies-to-offer-growth-monthly-income">New ETF Bets On Small Companies To Offer Growth, Monthly Income</a></strong></p>
<h2 class="wp-block-heading"><strong>The Middle Path Between FOMO And Fear</strong></h2>
<p>TSPY is somewhat of a middle-ground for investors stuck between fear of missing out and fear of losing everything, </p>
<p>&#8220;We stay fully invested in the S&amp;P 500 every day, while adding a consistent income engine that works in both calm and choppy markets,&#8221; Katara said.</p>
<p>Recent turmoil, such as the <a href="https://www.benzinga.com/news/25/04/44891038/clearly-word-got-out-scott-galloway-says-april-9-will-go-down-as-the-greatest-day-of-insider-trading-in-history">April 9 market shock</a>, has tested those income and risk-management capabilities. Within a mere 10 days of that occasion — when President Donald Trump suddenly paused tariffs for most countries while simultaneously raising them on China — TSPY made its first hedged trade.</p>
<p>Katara insists that the trade was made possible only by the fintech infrastructure they&#8217;d developed behind the scenes.</p>
<p>&#8220;To help manage that kind of risk, we've added tools like credit spreads and protective puts,&#8221; he explained, adding that It&#8217;s not a matter of moving fast, it&#8217;s about moving smartly.</p>
<h2 class="wp-block-heading"><strong>Risk Management Without Handcuffs</strong></h2>
<p>To shield investors from market swings, TSPY employs credit spreads and protective puts — tactical tools used selectively. ". The long call in a credit spread limits how much the fund can give up if the market suddenly spikes. The protective put does the same on the downside — acting like insurance during sharp drops," Katara explains. "These tools help us stay steady in turbulent markets without taking on more risk than we're comfortable with."</p>
<p>This degree of active management, day in and day out — strike choice, signal tracking, minute-by-minute adjustment — is all done on a rules-based, structured platform. &#8220;TSPY is actively managed every single trading day — we're dynamically selecting strikes, monitoring signals, and making adjustments based on data that's presented throughout the trading day,&#8221; he explained.</p>
<h2 class="wp-block-heading"><strong>Trade-Offs And Target Investors</strong></h2>
<p>Sure, there's a trade-off — TSPY caps some upside to fuel its income engine. But for many, it's a fair exchange. "it's about getting more from your core S&amp;P 500 exposure. We hold SPY dollar-for-dollar, just like <strong>Warren Buffett</strong> recommends for long-term investors. </p>
<p>Then we overlay a next-gen daily options strategy using 0DTE calls. This adds meaningful, tax-efficient income and lowers beta — without sacrificing market participation. In certain conditions, it can even help investors keep pace with or potentially outperform the index. The result: a steadier, smarter way to stay fully invested while putting your capital to work every day," Katara noted.</p>
<p>So, who&#8217;s the perfect investor? Katara sums it up: &#8220;Someone who believes in long-term equity growth but wants their capital to work harder every single day. It's a great fit for investors who value tax-efficient income, prefer consistency over big swings, and aren't chasing the stock of the week.&#8221;</p>
<p>Whether investors utilize TSPY as a new foundation holding, a substitute for half of their income sleeve, or merely as the &#8220;SPY with benefits,&#8221; its adaptable design and disciplined approach seek to make it better than another ETF in a sea of competition.</p>
<p>As Katara puts it: &#8220;Some call it their &#8216;AND&#8217; fund — SPY exposure…and tax-efficient income…and lower beta. Others see it as a &#8216;Next Gen SPY,&#8217; built for today's markets. However you frame it, TSPY is designed to flex across a wide range of portfolios.&#8221;</p>
<p><strong>Read More:<a href="https://www.benzinga.com/etfs/new-etfs/25/05/45173999/new-mst-etf-mixes-microstrategy-strategy-leverage-with-a-side-of-weekly-income"> </a></strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/etfs/new-etfs/25/05/45173999/new-mst-etf-mixes-microstrategy-strategy-leverage-with-a-side-of-weekly-income">New MST ETF Mixes MicroStrategy (Strategy) Leverage With A Side Of Weekly Income</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


ETFs

TSPY

'We're Not Guessing The Market, We're Managing It': Inside TSPY's Bold Strategy With CEO Si Katara

<p>Cryptocurrency markets are treading water as the market enters a quiet stretch ahead of a key week for macroeconomic data.</p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$97,490.40</td>
<td>+0.9%</td>
</tr>
<tr>
<td><strong>Ethereum</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$1,852.16</td>
<td>+0.2%</td>
</tr>
<tr>
<td><strong>Solana</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$149.98</td>
<td>-0.2%</td>
</tr>
<tr>
<td><strong>XRP </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.21</td>
<td>-0.5%</td>
</tr>
<tr>
<td><strong>Dogecoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1815</td>
<td>+0.2%</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001348</td>
<td>-1%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Notable Statistics:</strong></p>
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 19.6% and daily active addresses falling by 0.9%. Transactions greater than $100,000 are down from 10,529 to 10,084 in a single day. Exchanges netflows are down by 133.6%.</li>
<li>Coinglass data reports 71,325 traders were liquidated in the past 24 hours for $135.88 million.</li>
</ul>
<p><strong>Notable Developments:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45168129/bitcoin-up-25-from-tariff-lows-heres-the-case-for-new-all-time-highs-soon">Bitcoin Up 25% From Tariff Lows: Here&#8217;s THe Case For New All-Time Highs Soon</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45165364/aptos-eyes-real-world-utility-beyond-nfts-and-defi-says-ecosystem-head-ash-pampati">Aptos Eyes Real-World Utility Beyond NFTs And DeFi, Says Ecosystem Head Ash Pampati</a></li>
<li><a href="https://www.benzinga.com/25/05/45170022/bitcoin-hovers-around-97000-but-this-is-a-fragile-rally-analyst-warns">Bitcoin Hovers Around $97,000 But This Is A &#8216;Fragile Rally,&#8217; Analyst Warns</a></li>
<li><a href="https://www.benzinga.com/news/guidance/25/05/45152230/strategy-q1-earnings-bitcoin-treasury-company-raises-its-btc-yield-and-btc-gain-targets-for-2025">Strategy Q1 Earnings: Bitcoin Treasury Company Raises Its &#8216;BTC Yield&#8217; And &#8216;BTC $ Gain&#8217; Targets For 2025</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45154528/bitcoin-miner-riot-platforms-reports-q1-results-shares-slide">Bitcoin Miner Riot Platforms Reports Q1 Results, Shares Slide</a></li>
</ul>
<p><strong>Top Gainers:</strong></p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>Pudgy Penguins</strong> (CRYPTO: PENGU)</td>
<td>$0.01233</td>
<td>+13%</td>
</tr>
<tr>
<td><strong>EOS</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eos/usd">EOS</a>)</td>
<td>$1.85</td>
<td>+9.5%</td>
</tr>
<tr>
<td><strong>Immutable</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">IMX</a>)</td>
<td>$0.6441</td>
<td>+8.2%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Trader Notes: </strong>Bitcoin trader Cole sees Bitcoin forming a potential rising wedge, often a bearish pattern. With an uptick in long positions and light weekend liquidity, he warns of a possible pullback toward the daily open or support near $95,000–$95,500.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> watching Potiential rising wedge closely as we head into weekend. Low volume weekend can change things but we'll see. <br /><br />Seeing a lot of longs opening up here, see if we get a pullback to D/O or $95k-$95.5k support &#x1f91d;&#x1f3fb; <a href="https://t.co/pRZWN7mDRM">https://t.co/pRZWN7mDRM</a> <a href="https://t.co/8eztNTiP6z">pic.twitter.com/8eztNTiP6z</a></p>
<p>&mdash; Cole (@_ColesTrading) <a href="https://twitter.com/_ColesTrading/status/1918351013075128511?ref_src=twsrc%5Etfw">May 2, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>Titan of Crypto <a href="https://x.com/Washigorira/status/1918335784223904072">points</a> to the SuperGuppy indicator, which just flipped bullish on the weekly chart, signaling a momentum shift back in favor of the bulls and potentially confirming the start of a longer-term uptrend.</p>
<p>Adding to the bullish narrative, Ted Pillows <a href="https://x.com/TedPillows/status/1918310412073717802">compares</a> Bitcoin's structure to gold's previous rally pattern &#8211; accumulation, breakout, highs, then re-accumulation. He sees BTC currently beginning its next leg up, projecting a new high by Q2 2025 based on that historic rhythm.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> is just following Gold&#39;s rally.<br /><br />Accumulation phase followed by a breakout which led to a new ATH.<br /><br />After that, BTC entered the re-accumulation phase and broke out of it in Q4 2024.<br /><br />For the past few months, BTC was back into the consolidation phase and now it has started… <a href="https://t.co/UCDDvtxxmh">pic.twitter.com/UCDDvtxxmh</a></p>
<p>&mdash; Ted (@TedPillows) <a href="https://twitter.com/TedPillows/status/1918310412073717802?ref_src=twsrc%5Etfw">May 2, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>On-chain data from Glassnode strengthens the bull case:</p>
<ul>
<li>Long-term holders have <a href="https://x.com/glassnode/status/1918359719619477701">accumulated</a> over 254,000 BTC now aged past 155 days.</li>
<li>Many of these coins were bought above $95,000, and spending remains low, a sign of confidence and reduced desire to sell. </li>
<li>Additionally, BTC holders with 30+ day coins are now <a href="https://x.com/glassnode/status/1918274195886162299">back</a> in profit, easing potential sell pressure from short-term holders.</li>
</ul>
<p>Together, these signals point to early-stage bullish momentum, but with weekend volatility and leveraged longs building, traders remain cautious.</p>
<p><strong>Read Next:&nbsp;</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45164011/bitcoin-ethereum-xrp-dogecoin-sentiment-rebounds-as-btc-hits-97000">Bitcoin, Ethereum, XRP, Dogecoin Sentiment Rebounds As BTC Hits $97,000</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$EOS

$ETH

$IMX

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Hold Steady As Bulls Eye Further Gains

<p>RBC Capital  analyst Brad Heffern   maintains Invitation Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVH#NYSE">INVH</a>) with a Sector Perform and raises the price target from $35 to $36.</p>


INVH

RBC Capital Maintains Sector Perform on Invitation Homes, Raises Price Target to $36

AGAE

APTV

Adtalem Global Education Inc. Common Stock

ATGE

DASH

DKNG

DXLG

EDUC

FIGS

GRWG

MMYT

SBUX

SERV

SPHL

Shares of companies within the broader consumer discretionary sector are trading higher amid overall market strength following April's jobs data and reports that China's Commerce Ministry is assessing possible trade talks with the US.

<p>Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) will release its quarterly earnings report on Monday, 2025-05-05. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Lattice Semiconductor to report an <strong>earnings per share</strong> (EPS) of $0.22.</p>
<p>Anticipation surrounds Lattice Semiconductor's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company missed EPS by $0.04, leading to a 7.66% increase in the share price the following trading session.</p>

<p><img src="https://www.benzinga.com/files/images/story/2025/1746212649_0.png" alt="eps graph" /></p>
<h3>Market Performance of Lattice Semiconductor's Stock</h3>
<p>Shares of Lattice Semiconductor were trading at $48.97 as of May 01. Over the last 52-week period, shares are down 26.61%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Observations about Lattice Semiconductor</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Lattice Semiconductor.</p>
<p>The consensus rating for Lattice Semiconductor is Buy, based on 8 analyst ratings. With an average one-year price target of $76.25, there's a potential 55.71% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Credo Technology Group, Universal Display and Qorvo, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Credo Technology Group, with an average 1-year price target of $70.86, suggesting a potential 44.7% upside.</li>
<li>Analysts currently favor an Buy trajectory for Universal Display, with an average 1-year price target of $179.67, suggesting a potential 266.9% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Qorvo, with an average 1-year price target of $78.0, suggesting a potential 59.28% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>In the peer analysis summary, key metrics for Credo Technology Group, Universal Display and Qorvo are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lattice Semiconductor</td>
<td>Buy</td>
<td>-31.17%</td>
<td>$71.75M</td>
<td>2.33%</td>
</tr>
<tr>
<td>Credo Technology Group</td>
<td>Buy</td>
<td>154.44%</td>
<td>$85.93M</td>
<td>4.95%</td>
</tr>
<tr>
<td>Universal Display</td>
<td>Buy</td>
<td>2.51%</td>
<td>$124.94M</td>
<td>2.87%</td>
</tr>
<tr>
<td>Qorvo</td>
<td>Neutral</td>
<td>-5.11%</td>
<td>$391.42M</td>
<td>0.93%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Lattice Semiconductor ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.</p>
<h3>About Lattice Semiconductor</h3>
<p>Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.</p>
<h3>Understanding the Numbers: Lattice Semiconductor's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Lattice Semiconductor's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately <strong>-31.17%</strong>. This indicates a decrease in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Lattice Semiconductor's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>14.06%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Lattice Semiconductor's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>2.33%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Lattice Semiconductor's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>1.95%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Lattice Semiconductor's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.02</strong>.</p>
<p><a href="https://www.benzinga.com/quote/LSCC/earnings"><strong>To track all earnings releases for Lattice Semiconductor visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


LSCC

Lattice Semiconductor's Earnings: A Preview

<p><strong>Reddit, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Friday.</a></p>
<p>On Thursday, <strong> </strong>Reddit reported first quarter earnings of 13 cents per share, which <a href="https://www.benzinga.com/general/social-media/25/05/45151798/reddit-stock-soars-after-better-than-expected-q1-daily-active-uniques-up-31-ad-revenue-up-61-and-more" target="_blank" rel="noreferrer noopener">beat the analyst consensus estimate of two cents</a>. Quarterly revenue of $392.36 million beat the street consensus expectations for $370.01 million and is an increase of revenue of $242.96 million from the same period last year.</p>
<p>Here are the analysts&#8217; takes on the stock:</p>
<ul>
<li><strong>Needham </strong>analyst Laura Martin reiterated a Buy rating on Reddit, raising the price forecast from $135 to $145.</li>
<li><strong>JP Morgan</strong>&#8216;s Doug Anmuth reiterated a Neutral rating on the stock, raising the target price from $110 to $145.</li>
<li><strong>Citizens</strong>&#8216;s Andrew Boone maintained their Market Outperform rating, increasing the forecast from $155 to $180.</li>
<li><strong>Guggenheim </strong>analyst Michael Morris reiterated a Buy rating, trimming the prediction from $170 to $165.</li>
</ul>
<p><strong>Also Read:<a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45157434/reddit-says-40-of-comment-section-discussions-are-about-products-services-so-now-theyre-ad-space" rel="noreferrer noopener"> Reddit Stock Spikes Over 6% After-hours After Earning Beat, Platform Considers Putting Ads In Comments To Monetize High &#8216;Engagement&#8217;</a></strong></p>
<p><strong>Needham: </strong>Martin highlighted several positives from Reddit&#8217;s Q1 results, including strong revenue and margin growth, better ad performance with a shift toward full-funnel advertisers, rising daily active users, promising new features like Reddit Search and Answers boosting engagement, solid free cash flow, and AI-driven language tools expected to support international user growth in FY25.</p>
<p>The analyst raised the firm&#8217;s FY25 revenue estimate from $1.722 billion to $1.795 billion.</p>
<p><strong>JP Morgan:</strong> The analyst projects Reddit to maintain strong revenue growth and improve profitability as it expands its ad offerings and targets a 40% long-term adjusted EBITDA margin.</p>
<p>While recent estimate upgrades reflect renewed confidence after earlier recession-related cuts, the analyst cautions that uncertainty around changes in Google&#8217;s search ecosystem remains a long-term risk. Projected average growth for 2025 and 2026 stands at 12% for revenue, 33% for adjusted EBITDA, and 34% for free cash flow, which the analyst believes justifies Reddit's premium valuation.</p>
<p><strong>Citizens: </strong>Boone writes that Reddit is largely insulated from tariff-related risks due to its limited reliance on retail ad spending and relatively modest ad revenue in 2023.</p>
<p>While a broader recession could affect the company, sector-specific macro headwinds are unlikely to cause major disruption, given Reddit&#8217;s lower exposure to the most impacted ad budgets.</p>
<p><strong>Guggenheim: </strong>The analyst noted that while management recognized ongoing market uncertainty, they characterized current conditions as stable.</p>
<p>Advertising performance stood out, with pricing growth for the first time since Reddit's IPO, driven by progress in mid- and lower-funnel ad strategies, which now account for 60% of ad revenue.</p>
<p>Broad strength was seen across ad verticals, with 10 out of 15 growing over 50% year-over-year, alongside a 50% increase in active advertisers.</p>
<p><strong>Price Action:</strong> RDDT shares are trading higher by 1.47% to $120.80&nbsp;at last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45164558/us-adds-177000-jobs-in-april-topping-forecasts-as-economy-navigates-tariff-impact" target="_blank" rel="noreferrer noopener">April Jobs Blow Past Expectations, But Tariff Storm May Be Brewing</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Equities

Markets

Movers

Trading Ideas

General

RDDT

Reddit's Ad Strategy Is Clicking, Say Analysts—Strong Q1 Sets Stage For Profitable Growth in 2025

<p>RBC Capital  analyst Deane Dray   maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Outperform and raises the price target from $206 to $208.</p>


RBC Capital Maintains Outperform on IDEX, Raises Price Target to $208

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Walmart</strong>.</p>
<p>Looking at options history for Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) we detected 24 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 45% with bearish.</p>
<p>From the overall spotted trades, 10 are puts, for a total amount of $645,291 and 14, calls, for a total amount of $647,134.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $70.0 to $105.0 for Walmart over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Walmart's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Walmart's substantial trades, within a strike price spectrum from $70.0 to $105.0 over the preceding 30 days.</p>
<h3>Walmart Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746212594_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$14.05</td>
<td>$13.9</td>
<td>$13.9</td>
<td>$92.50</td>
<td>$162.6K</td>
<td>1.9K</td>
<td>117</td>
</tr>
<tr>
<td>WMT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$3.75</td>
<td>$3.65</td>
<td>$3.74</td>
<td>$95.00</td>
<td>$149.6K</td>
<td>3.0K</td>
<td>439</td>
</tr>
<tr>
<td>WMT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$0.46</td>
<td>$0.45</td>
<td>$0.45</td>
<td>$80.00</td>
<td>$91.4K</td>
<td>43.4K</td>
<td>3.0K</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.6</td>
<td>$6.45</td>
<td>$6.6</td>
<td>$95.00</td>
<td>$66.0K</td>
<td>8.7K</td>
<td>109</td>
</tr>
<tr>
<td>WMT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$100.00</td>
<td>$63.3K</td>
<td>2.4K</td>
<td>455</td>
</tr>
</tbody>
</table>
</p>
<h3>About Walmart</h3>
<p>Walmart serves as a leading retailer in the United States, with its strategy predicated on superior operating efficiency and offering the lowest priced goods to consumers to drive robust store traffic and product turnover. Walmart augmented its low-price business strategy by offering a convenient one-stop shopping destination with the opening of its first supercenter in 1988.Today, Walmart operates over 4,600 stores in the United States (5,200 including Sam's Club) and over 10,000 locations globally. Walmart generated over $460 billion in domestic namesake sales in fiscal 2025, with Sam's Club contributing another $90 billion to the company's top line. Internationally, Walmart generated $120 billion in sales. The retailer serves around 270 million customers globally each week.</p>
<p>Having examined the options trading patterns of Walmart, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Walmart's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 10,289,219, the WMT's price is up by 1.33%, now at $98.71. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 13 days.</li>
</ul>
<h3>What The Experts Say On Walmart</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $105.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Mizuho lowers its rating to Outperform with a new price target of $105.<br />
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Walmart, targeting a price of $115.<br />
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Walmart, which currently sits at a price target of $110.<br />
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Walmart, targeting a price of $95.<br />
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Walmart with a target price of $100. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Walmart with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

Behind the Scenes of Walmart's Latest Options Trends

<p>Financial giants have made a conspicuous bearish move on Palantir Technologies. Our analysis of options history for Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) revealed 82 unusual trades.</p>
<p>Delving into the details, we found 43% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 25 were puts, with a value of $1,752,872, and 57 were calls, valued at $5,808,704.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $3.0 to $185.0 for Palantir Technologies during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Palantir Technologies's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Palantir Technologies's whale trades within a strike price range from $3.0 to $185.0 in the last 30 days. </p>
<h3>Palantir Technologies Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746212589_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$13.0</td>
<td>$12.95</td>
<td>$12.95</td>
<td>$125.00</td>
<td>$710.9K</td>
<td>7.0K</td>
<td align="right">834</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$5.05</td>
<td>$4.95</td>
<td>$5.05</td>
<td>$80.00</td>
<td>$432.1K</td>
<td>5.5K</td>
<td align="right">914</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$120.65</td>
<td>$119.5</td>
<td>$119.51</td>
<td>$3.00</td>
<td>$394.3K</td>
<td>945</td>
<td align="right">44</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$118.7</td>
<td>$117.6</td>
<td>$117.6</td>
<td>$5.00</td>
<td>$388.0K</td>
<td>563</td>
<td align="right">8</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/17/27</td>
<td>$62.45</td>
<td>$62.0</td>
<td>$62.0</td>
<td>$100.00</td>
<td>$117.8K</td>
<td>2.6K</td>
<td align="right">59</td>
</tr>
</tbody>
</table>
</p>
<h3>About Palantir Technologies</h3>
<p>Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.</p>
<p>Having examined the options trading patterns of Palantir Technologies, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Palantir Technologies's Current Market Status</h3>
<ul>
<li>Trading volume stands at 80,340,108, with PLTR's price up by 6.66%, positioned at $123.94.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 3 days.</li>
</ul>
<h3>Professional Analyst Ratings for Palantir Technologies</h3>
<p>Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $76.67.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Morgan Stanley persists with their Equal-Weight rating on Palantir Technologies, maintaining a target price of $90.<br />
&#x2A; An analyst from RBC Capital downgraded its action to Underperform with a price target of $40.<br />
&#x2A; An analyst from DA Davidson has decided to maintain their Neutral rating on Palantir Technologies, which currently sits at a price target of $100. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Palantir Technologies options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


PLTR

Palantir Technologies's Options Frenzy: What You Need to Know

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Goldman Sachs Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GS, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 41 uncommon options trades for Goldman Sachs Group.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 51% bullish and 41%, bearish.</p>
<p>Out of all of the special options we uncovered, 22 are puts, for a total amount of $785,790, and 19 are calls, for a total amount of $1,106,030.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $300.0 to $620.0 for Goldman Sachs Group during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Goldman Sachs Group stands at 332.2, with a total volume reaching 1,888.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Goldman Sachs Group, situated within the strike price corridor from $300.0 to $620.0, throughout the last 30 days.</p>
<h3>Goldman Sachs Group 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746212583_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$16.4</td>
<td>$10.85</td>
<td>$15.0</td>
<td>$550.00</td>
<td>$150.0K</td>
<td align="right">585</td>
<td align="right">0</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$52.4</td>
<td>$51.8</td>
<td>$52.4</td>
<td>$560.00</td>
<td>$104.8K</td>
<td align="right">263</td>
<td align="right">20</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$65.0</td>
<td>$61.3</td>
<td>$65.0</td>
<td>$500.00</td>
<td>$84.5K</td>
<td align="right">325</td>
<td align="right">13</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$166.7</td>
<td>$161.55</td>
<td>$166.0</td>
<td>$400.00</td>
<td>$83.0K</td>
<td align="right">39</td>
<td align="right">5</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$79.1</td>
<td>$75.2</td>
<td>$77.94</td>
<td>$495.00</td>
<td>$77.9K</td>
<td align="right">36</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Goldman Sachs Group</h3>
<p>Goldman Sachs is a leading global investment banking and asset management firm. Approximately 14% of its revenue comes from investment banking, 42% from trading, 20% from asset &amp; wealth management, 15% from net interest income, and 9% from other principal transactions. Around 64% of the company's net revenue is generated in the Americas, 13% in Asia, and 23% in Europe, the Middle East, and Africa.</p>
<p>After a thorough review of the options trading surrounding Goldman Sachs Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Goldman Sachs Group Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,825,980, with GS's price up by 2.3%, positioned at $566.58.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 75 days.</li>
</ul>
<h3>What Analysts Are Saying About Goldman Sachs Group</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $628.8.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Goldman Sachs Group, targeting a price of $614.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Goldman Sachs Group with a target price of $720.<br />
&#x2A; Maintaining their stance, an analyst from JMP Securities continues to hold a Market Outperform rating for Goldman Sachs Group, targeting a price of $600.<br />
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Goldman Sachs Group, targeting a price of $650.<br />
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Sector Perform rating on Goldman Sachs Group with a target price of $560. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Goldman Sachs Group with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


This Is What Whales Are Betting On Goldman Sachs Group

TTMI

TTM Technologies shares are trading higher after the company on Wednesday reported better-than-expected Q1 financial results and issued Q2 guidance above estimates.

<p>RBC Capital  analyst Ken Herbert   maintains Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) with a Outperform and raises the price target from $150 to $165.</p>


RBC Capital Maintains Outperform on Howmet Aerospace, Raises Price Target to $165

<p><strong>Duolingo Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) <a target="_blank" href="https://www.benzinga.com/topic/duolingo" rel="noreferrer noopener">stock traded higher</a> on Friday after the company reported better-than-expected first-quarter financial results on Thursday.</p>
<p>Wall Street analysts raised their price targets on the stock.</p>
<p>Needham analyst Ryan MacDonald maintained Duolingo with a Buy and raised the <a target="_blank" href="https://www.benzinga.com/quote/DUOL/analyst-ratings" rel="noreferrer noopener">price target from</a> $400&nbsp;to&nbsp;$460.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44047945/duolingos-ai-investments-set-the-stage-for-long-term-growth-analyst-sees-stock-hitting-400" target="_blank" rel="noreferrer noopener">Duolingo&#8217;s AI Investments Set The Stage For Long-Term Growth—Analyst Sees Stock Hitting $400</a></strong></p>
<p>The company reported quarterly revenue growth of 38% to $230.74 million, beating the analyst consensus estimates of $222.98 million. EPS of $0.72 beat the <a target="_blank" href="https://investors.duolingo.com/investor-relations" rel="noreferrer noopener">analyst consensus estimate</a> of $0.51.</p>
<p>This quarter&#8217;s top-line outperformance was mainly driven by Subscriptions, which topped estimates, driven by better-than-expected subscriber count and revenue per subscriber. Paid subscribers came in at 10.3 million for the quarter, above the consensus of 10.12 million. Gross margins exceeded the analyst estimate of 70.0% at 71.1% but were down from 73.0% a year ago. </p>
<p>The decline was expected and due to a combination of lower subscription margins from increased generative AI costs associated with increased Duolingo Max adoption. However, management noted they benefited from some earlier-than-expected cost optimization and higher than anticipated advertising gross margin in other revenue.</p>
<p>Daily active users (DAUs) were 46.6 million, an increase of 49%, and monthly active users (MAUs) were 130.2 million, an increase of 33%.</p>
<p>A viral campaign helps drive record MAU adds, while Max adoption continues at a similar rate to the fourth quarter. Subscription bookings were strong in the quarter, with Y/Y growth at 43.8% versus the analyst&#8217;s 35% growth estimate, resulting in subscription bookings of $232.2 million, above the consensus of $218.5 million.</p>
<p>Duolingo expects second-quarter&nbsp;revenue of&nbsp;$238.50 million-$241.50 million&nbsp;versus&nbsp;the $233.76 million&nbsp;analyst consensus estimate. MacDonald expects quarterly revenue of $240.12 million.</p>
<p>Duolingo raised its fiscal 2025 revenue outlook&nbsp;from&nbsp;$962.50 million-$978.50 million&nbsp;to&nbsp;$987.00 million-$996.00 million&nbsp;versus&nbsp;the $977.16 million&nbsp;estimate. MacDonald expects fiscal revenue of $991.51 million.</p>
<p>Duolingo stock continued its strong run to start 2025, with shares up 23.4% year-to-date and 79.4% in the past year. While the stock is trading at a premium multiple to the comp group, and MacDonald&#8217;s new price target represents a 22.1 times EV/sales multiple on his fiscal 2025 estimates, the analyst noted that the strong year-end subscription bookings likely translate into subscription revenue growth in the mid-40s range for fiscal 2025 versus the current consensus of 38.3%.</p>
<p><strong>Price Action</strong>: DUOL shares traded higher by 18.5% at $474.13 at last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/government/regulations/25/05/45168490/us-listed-chinese-stocks-soar-on-hopes-for-us-china-trade-truce" target="_blank" rel="noreferrer noopener">US Listed Chinese Stocks Soar On Hopes for US-China Trade Truce</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Reiteration

DUOL

Duolingo Charms Wall Street With Viral Surge, AI Power, Soaring Subscriptions

<p>National Health Investors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NHI#NYSE">NHI</a>) is preparing to release its quarterly earnings on Monday, 2025-05-05. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect National Health Investors to report an <strong>earnings per share</strong> (EPS) of $1.13.</p>
<p>National Health Investors bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.02, which was followed by a 0.17% drop in the share price the next day.</p>
<p>Here's a look at National Health Investors's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.10</td>
<td>1.08</td>
<td></td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.12</td>
<td>1.03</td>
<td>1.18</td>
<td>1.12</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>0.0%</td>
<td>0.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>Tracking National Health Investors's Stock Performance</h3>
<p>Shares of National Health Investors were trading at $75.37 as of May 01. Over the last 52-week period, shares are up 17.99%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Insights Shared by Analysts on National Health Investors</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on National Health Investors.</p>
<p>The consensus rating for National Health Investors is Neutral, derived from 2 analyst ratings. An average one-year price target of $82.0 implies a potential 8.8% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Sabra Health Care REIT, American Healthcare REIT and LTC Properties, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Sabra Health Care REIT, with an average 1-year price target of $19.0, suggesting a potential 74.79% downside.</li>
<li>Analysts currently favor an Outperform trajectory for American Healthcare REIT, with an average 1-year price target of $35.4, suggesting a potential 53.03% downside.</li>
<li>Analysts currently favor an Neutral trajectory for LTC Properties, with an average 1-year price target of $38.0, suggesting a potential 49.58% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Sabra Health Care REIT, American Healthcare REIT and LTC Properties, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>National Health Investors</td>
<td>Neutral</td>
<td>7.92%</td>
<td>$82.91M</td>
<td>3.33%</td>
</tr>
<tr>
<td>Sabra Health Care REIT</td>
<td>Neutral</td>
<td>11.60%</td>
<td>$122.51M</td>
<td>1.70%</td>
</tr>
<tr>
<td>American Healthcare REIT</td>
<td>Outperform</td>
<td>12.47%</td>
<td>$112.17M</td>
<td>-1.42%</td>
</tr>
<tr>
<td>LTC Properties</td>
<td>Neutral</td>
<td>4.76%</td>
<td>$49.47M</td>
<td>1.88%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>National Health has the highest revenue growth among peers. It also leads in gross profit margin. However, it has the lowest return on equity.</p>
<h3>Delving into National Health Investors's Background</h3>
<p>National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.</p>
<h3>Financial Insights: National Health Investors</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> National Health Investors's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>7.92%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> National Health Investors's net margin is impressive, surpassing industry averages. With a net margin of <strong>50.39%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>3.33%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> National Health Investors's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.7%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.84</strong>.</p>
<p><a href="https://www.benzinga.com/quote/NHI/earnings"><strong>To track all earnings releases for National Health Investors visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Exploring National Health Investors's Earnings Expectations

FTDR

Frontdoor shares are trading higher after the company reported better-than-expected Q1 financial results and raised tis FY25 sales guidance above estimates. Also, the company issued Q2 sales guidance above estimates.

<p>In the last three months, 15 analysts have published ratings on American International Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated American International Gr and provided 12-month price targets. The average target is $89.0, accompanied by a high estimate of $98.00 and a low estimate of $76.00. Surpassing the previous average price target of $85.60, the current average has increased by 3.97%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746212476_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The standing of American International Gr among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$93.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$92.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$95.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$81.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$94.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$91.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Michael Phillips</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$82.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$98.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$87.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$98.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$89.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$83.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$86.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Michael Phillips</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$76.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to American International Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of American International Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of American International Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of American International Gr's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AIG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on American International Gr analyst ratings.</strong></a></p>
<h2>Delving into American International Gr's Background</h2>
<p>American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.</p>
<h3>Unraveling the Financial Story of American International Gr</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Revenue Growth:</strong> American International Gr displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>9.91%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> American International Gr's net margin excels beyond industry benchmarks, reaching <strong>12.51%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> American International Gr's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>2.05%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.54%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> American International Gr's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.21</strong>.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


American International Gr Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)

Management

Press Releases

Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

Health Care

Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20

Vaxart Provides Business Update and Reports Full Year 2024 Financial Results

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vaxartto Present at World Vaccine Congress Washington 2025 on April 23

Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate

Vaxart to Present at the Citizens Life Sciences Conference

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13

Comments

Vaxart

Vaxart (VXRT) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO